Brief: Clearmind Medicine Successfully Completes Part A Of Its FDA Regulated Phase I/Ii Trial
BRIEF-Clearmind Medicine Successfully Completes Part A Of Its FDA Regulated Phase I/Ii Trial July 28 (Reuters) - Clearmind Medicine Inc CMND.O:
CLEARMIND MEDICINE SUCCESSFULLY COMPLETES PART A OF ITS FDA REGULATED PHASE I/II TRIAL
Source text: ID:nGNXKF8Xc
Further company coverage: CMND.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM